Corrigendum to “Adaphostin and bortezomib induce oxidative injury and apoptosis in imatinib mesylate-resistant hematopoietic cells expressing mutant forms of Bcr/Abl” [Leuk. Res. 30 (2006) 1263–1272]
Gespeichert in:
Veröffentlicht in: | Leukemia research 2019-07, Vol.82, p.46-47 |
---|---|
Hauptverfasser: | , , , |
Format: | Artikel |
Sprache: | eng |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 47 |
---|---|
container_issue | |
container_start_page | 46 |
container_title | Leukemia research |
container_volume | 82 |
creator | Dasmahapatra, Girija Nguyen, Tri K. Dent, Paul Grant, Steven |
description | |
doi_str_mv | 10.1016/j.leukres.2019.03.002 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2231966078</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0145212619300487</els_id><sourcerecordid>2231966078</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1580-23480441f352bf282b2ac78a60a91b70af65377167cd6aae89ad4bc9f5c254d23</originalsourceid><addsrcrecordid>eNqFkU2O1DAQhSMEYpqBI4C8HBbJlO38rlDT4k9qCQnBCiHLsSszbpI42M5omlXfgS0ciUv0SXBPN2xZlVT1vSo_vyR5SiGjQMvLTdbj_NWhzxjQJgOeAbB7yYLWFU-Lmhf3kwXQvEgZZeVZ8sj7DQAUDW0eJmecQtXUFSyS3yvrnLnCUc8DCZbsdz-XWk7X1gczEjlq0loX8LsdTEtMpBQSe2u0DOYGY2Mzu-0dJic7BeuNj01ihjgfo2JAv-1lwDQ-1Pggx0CuMQ7tZA0Go4jCvvcEb6cIeDNekWG-ozrrBk9sR14qd7ls-_3uF_m8jo4z8iF6JhzIBQMon5Noj-93Pyir2JfHyYNO9h6fnOp58un1q4-rt-n6_Zt3q-U6VbSoIWU8ryHPaccL1nasZi2TqqplCbKhbQWyKwteVbSslC6lxLqROm9V0xWKFblm_Dy5OO6dnP02ow9iMP5gRY5oZy8Y47QpS6jqiBZHVDnrvcNOTC5-j9sKCuKQpNiIU5LikKQALmKSUffsdGJuB9T_VH-ji8CLI4DR6I1BJ7wyOCrUxqEKQlvznxN_APwttqA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2231966078</pqid></control><display><type>article</type><title>Corrigendum to “Adaphostin and bortezomib induce oxidative injury and apoptosis in imatinib mesylate-resistant hematopoietic cells expressing mutant forms of Bcr/Abl” [Leuk. Res. 30 (2006) 1263–1272]</title><source>Elsevier ScienceDirect Journals</source><creator>Dasmahapatra, Girija ; Nguyen, Tri K. ; Dent, Paul ; Grant, Steven</creator><creatorcontrib>Dasmahapatra, Girija ; Nguyen, Tri K. ; Dent, Paul ; Grant, Steven</creatorcontrib><identifier>ISSN: 0145-2126</identifier><identifier>EISSN: 1873-5835</identifier><identifier>DOI: 10.1016/j.leukres.2019.03.002</identifier><identifier>PMID: 31079870</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><ispartof>Leukemia research, 2019-07, Vol.82, p.46-47</ispartof><rights>2019 Elsevier Ltd</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0145212619300487$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65534</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31079870$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Dasmahapatra, Girija</creatorcontrib><creatorcontrib>Nguyen, Tri K.</creatorcontrib><creatorcontrib>Dent, Paul</creatorcontrib><creatorcontrib>Grant, Steven</creatorcontrib><title>Corrigendum to “Adaphostin and bortezomib induce oxidative injury and apoptosis in imatinib mesylate-resistant hematopoietic cells expressing mutant forms of Bcr/Abl” [Leuk. Res. 30 (2006) 1263–1272]</title><title>Leukemia research</title><addtitle>Leuk Res</addtitle><issn>0145-2126</issn><issn>1873-5835</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><recordid>eNqFkU2O1DAQhSMEYpqBI4C8HBbJlO38rlDT4k9qCQnBCiHLsSszbpI42M5omlXfgS0ciUv0SXBPN2xZlVT1vSo_vyR5SiGjQMvLTdbj_NWhzxjQJgOeAbB7yYLWFU-Lmhf3kwXQvEgZZeVZ8sj7DQAUDW0eJmecQtXUFSyS3yvrnLnCUc8DCZbsdz-XWk7X1gczEjlq0loX8LsdTEtMpBQSe2u0DOYGY2Mzu-0dJic7BeuNj01ihjgfo2JAv-1lwDQ-1Pggx0CuMQ7tZA0Go4jCvvcEb6cIeDNekWG-ozrrBk9sR14qd7ls-_3uF_m8jo4z8iF6JhzIBQMon5Noj-93Pyir2JfHyYNO9h6fnOp58un1q4-rt-n6_Zt3q-U6VbSoIWU8ryHPaccL1nasZi2TqqplCbKhbQWyKwteVbSslC6lxLqROm9V0xWKFblm_Dy5OO6dnP02ow9iMP5gRY5oZy8Y47QpS6jqiBZHVDnrvcNOTC5-j9sKCuKQpNiIU5LikKQALmKSUffsdGJuB9T_VH-ji8CLI4DR6I1BJ7wyOCrUxqEKQlvznxN_APwttqA</recordid><startdate>201907</startdate><enddate>201907</enddate><creator>Dasmahapatra, Girija</creator><creator>Nguyen, Tri K.</creator><creator>Dent, Paul</creator><creator>Grant, Steven</creator><general>Elsevier Ltd</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>201907</creationdate><title>Corrigendum to “Adaphostin and bortezomib induce oxidative injury and apoptosis in imatinib mesylate-resistant hematopoietic cells expressing mutant forms of Bcr/Abl” [Leuk. Res. 30 (2006) 1263–1272]</title><author>Dasmahapatra, Girija ; Nguyen, Tri K. ; Dent, Paul ; Grant, Steven</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1580-23480441f352bf282b2ac78a60a91b70af65377167cd6aae89ad4bc9f5c254d23</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Dasmahapatra, Girija</creatorcontrib><creatorcontrib>Nguyen, Tri K.</creatorcontrib><creatorcontrib>Dent, Paul</creatorcontrib><creatorcontrib>Grant, Steven</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Leukemia research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Dasmahapatra, Girija</au><au>Nguyen, Tri K.</au><au>Dent, Paul</au><au>Grant, Steven</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Corrigendum to “Adaphostin and bortezomib induce oxidative injury and apoptosis in imatinib mesylate-resistant hematopoietic cells expressing mutant forms of Bcr/Abl” [Leuk. Res. 30 (2006) 1263–1272]</atitle><jtitle>Leukemia research</jtitle><addtitle>Leuk Res</addtitle><date>2019-07</date><risdate>2019</risdate><volume>82</volume><spage>46</spage><epage>47</epage><pages>46-47</pages><issn>0145-2126</issn><eissn>1873-5835</eissn><cop>England</cop><pub>Elsevier Ltd</pub><pmid>31079870</pmid><doi>10.1016/j.leukres.2019.03.002</doi><tpages>2</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0145-2126 |
ispartof | Leukemia research, 2019-07, Vol.82, p.46-47 |
issn | 0145-2126 1873-5835 |
language | eng |
recordid | cdi_proquest_miscellaneous_2231966078 |
source | Elsevier ScienceDirect Journals |
title | Corrigendum to “Adaphostin and bortezomib induce oxidative injury and apoptosis in imatinib mesylate-resistant hematopoietic cells expressing mutant forms of Bcr/Abl” [Leuk. Res. 30 (2006) 1263–1272] |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-13T23%3A05%3A49IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Corrigendum%20to%20%E2%80%9CAdaphostin%20and%20bortezomib%20induce%20oxidative%20injury%20and%20apoptosis%20in%20imatinib%20mesylate-resistant%20hematopoietic%20cells%20expressing%20mutant%20forms%20of%20Bcr/Abl%E2%80%9D%20%5BLeuk.%20Res.%2030%20(2006)%201263%E2%80%931272%5D&rft.jtitle=Leukemia%20research&rft.au=Dasmahapatra,%20Girija&rft.date=2019-07&rft.volume=82&rft.spage=46&rft.epage=47&rft.pages=46-47&rft.issn=0145-2126&rft.eissn=1873-5835&rft_id=info:doi/10.1016/j.leukres.2019.03.002&rft_dat=%3Cproquest_cross%3E2231966078%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2231966078&rft_id=info:pmid/31079870&rft_els_id=S0145212619300487&rfr_iscdi=true |